Avatar photo

News

Replimune Investors: Rosen Law Firm Deadline Approaching

Rosen Law Firm is reminding investors who purchased Replimune Group, Inc. (NASDAQ: REPL) securities between November 22, 2024, and July 21, 2025, of the September 22, 2025, deadline to become a lead plaintiff in a class action lawsuit. The firm alleges materially misleading statements were made.

CleaDeep‘s P1 Range Hood: Labor Day Sale

CleaDeep is offering a Labor Day sale on its P1 range hood. The powerful hood boasts innovative technology for cleaner air and easier maintenance. This limited-time offer includes a significant discount and free installation.

FTI Consulting Appoints Hitesh Tak in Singapore

FTI Consulting has appointed Hitesh Tak as a Senior Managing Director in its Singapore office. Tak brings over 25 years of experience in operational improvements and strategic planning across various sectors in Southeast Asia. This appointment strengthens FTI Consulting's Corporate Finance & Restructuring segment in the region.

Fed‘s Powell: US Job Growth Slows Sharply

Federal Reserve Chair Jerome Powell recently indicated a weakening labor market, suggesting a potential interest rate cut. However, recent job reports have been revised downward, casting doubt on the strength of previous employment figures. This impacts Powell's decision-making process.

Faraday Future‘s Jia Announces Middle East Launch

Faraday Future (FFAI) Co-CEO YT Jia announced the Middle East launch of the FX Super One for late October, with sales beginning in November. This launch is a key step in FF's global expansion strategy and its dual-flywheel business model.

Tripathi Foundation Unveils AI Safety Framework

Tripathi Foundation announced its groundbreaking "Absolute Neutrality Framework" for AI safety. The framework uses universal principles to ensure AI remains safe, transparent, and aligned with humanity, incorporating continuous audits and automatic shutdown protocols. Carine Vieira provided contact information.

Zai Lab‘s TIVDAK Approved in Hong Kong

Zai Lab announced Hong Kong's approval of TIVDAK (tisotumab vedotin-tftv) for recurrent or metastatic cervical cancer. This expands TIVDAK's reach in Greater China and provides a new treatment option for patients. The drug is also under review in mainland China.

iRobot Investors’ Rosen Law Firm Deadline Approaches

Rosen Law Firm is reminding iRobot (NASDAQ: IRBT) investors who suffered losses exceeding $100,000 between January 29, 2024, and March 11, 2025, of the September 5th lead plaintiff deadline in a securities fraud lawsuit. Investors may be eligible for compensation. Contact Rosen Law Firm for details.